BioNxt Solutions (XTER:BXT) Accounts Payable: €0.43 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:BXT BioNxt Solutions Inc XTER:BXT
31 GF Score
Price €0.18
! 4 Warning Signs
View Full Analysis

What is BioNxt Solutions Accounts Payable?

BioNxt Solutions XTER:BXT -9.27% 31 Accounts Payable is €0.43 Mil as of Mar. 2026. GuruFocus rates XTER:BXT with a GF Score™ of 31/100. The stock has 4 warning signs investors should review.

BioNxt Solutions's Accounts Payable for the quarter that ended in Mar. 2026 was €0.43 Mil.

BioNxt Solutions's quarterly Accounts Payable increased from Sep. 2025 (€0.30 Mil) to Dec. 2025 (€0.44 Mil) but then declined from Dec. 2025 (€0.44 Mil) to Mar. 2026 (€0.43 Mil).

BioNxt Solutions's annual Accounts Payable increased from Dec. 2023 (€0.41 Mil) to Dec. 2024 (€0.75 Mil) but then declined from Dec. 2024 (€0.75 Mil) to Dec. 2025 (€0.44 Mil).

BioNxt Solutions Accounts Payable Related Terms

BioNxt Solutions Accounts Payable Historical Data

* Premium members only.

The historical data trend for BioNxt Solutions's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioNxt Solutions Accounts Payable Chart

BioNxt Solutions Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 0.36 0.32 0.41 0.75 0.44

BioNxt Solutions Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.62 0.30 0.44 0.43
XTER:BXT
31GF Score
BioNxt Solutions Inc XTER:BXT
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioNxt Solutions Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €0.43 Mil mean?
BioNxt Solutions (XTER:BXT) has a Accounts Payable of €0.43 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on BioNxt Solutions and its competitors.
Is BioNxt Solutions' Accounts Payable too high?
BioNxt Solutions' current Accounts Payable is €0.43 Mil. Overall, BioNxt Solutions has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does BioNxt Solutions' Accounts Payable compare to ZTS?
BioNxt Solutions' Accounts Payable of €0.43 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on BioNxt Solutions and its competitors. BioNxt Solutions's current Accounts Payable is €0.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioNxt Solutions stock overvalued right now?
BioNxt Solutions (XTER:BXT) has a current Accounts Payable of €0.43 Mil. The current Accounts Payable is €0.43 Mil. BioNxt Solutions' overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For BioNxt Solutions (XTER:BXT), the current Accounts Payable is €0.43 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioNxt Solutions Business Description

Address 1928 Linden Road, Vancouver, BC, CAN, V6M 1E7
BioNxt Solutions Inc is is a bioscience innovator focused on next-generation drug delivery systems. With research and development operations in North America and Europe, BioNxt is advancing regulatory approvals and commercialization efforts, focused on European markets. The company is committed to improving healthcare by delivering precise, patient-centric solutions that enhance treatment outcomes. Its pipeline includes BNT23001, BNT23002, BNT24002, BNT24003, BNT24004. Its geographic areas are Austria, Germany, Switzerland regions.
31GF Score

Get the complete analysis for XTER:BXT

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.18
Price